Skip to content

Use of the Individual Challenge Inventory Tool (ICIT) by General Practitioners

Can the Use of the Conversation Tool Individual Challenge Inventory Tool (ICIT) by General Practitioners Increase Coping of the Patients?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05128019
Acronym
ICIT
Enrollment
459
Registered
2021-11-19
Start date
2022-03-07
Completion date
2023-02-28
Last updated
2023-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical Unexplained Physical Symptoms (MUPS), Subjective Health Complaint

Keywords

MUPS, SHC, sick leave, Communication tool, General practice

Brief summary

Many patients in general practice present symptoms that do not refer to specific pathology. We refer to these patients at Medical Unexplained Physical Symptoms (MUPS). Practice and research have well documented that these patients frustrate most General Practitioners (GPs). They also produce a lot of unnecessary investigations and are overrepresented on sick-listing. The conversational tool Individual Challenge Inventory Tool (ICIT) offers an aid for the GPS to the consultation and aims to increase the patients' coping abilities with their health challenges. The aim of the study is to investigate whether patients experience such increased coping following a session of consultations with their GP based on ICIT.

Detailed description

The study is a Cluster Randomized Controlled Trial (cRCT) with GPs as clusters. We plan to includ 50 GPs to participate as intervention group and 50 GPs as controls. Each cluster will include 10 patients. GPs in the intervention group will be trained in the use of ICIT through a 30 hours course, partly digital and partly in presence. The participants will receive lectures on the background for the conversation tool, and the study, and will practice on each other. At the end of the study, also the 50 GPs of the control group will be invited to an identical course. The outcome of the study is any changes of the patients coping abilities. If the symptoms cannot be healed, a goal for the patients will be to reduce the impact of the symptoms. In practice, this is to reuptake normal activities, including work, in spite of pain, fatigue or mood disturbances. Through the ICIT, the patients will be challenged to look at themselves in a broader spectrum and decide for themselves which activities are possible to reuptake and making a thorough plan for doing so. The patients will be treated by their regular GP across several meetings and they will agree on a specific plan across weeks or months to achieve their individual goal. The patients of the GPs in the control group will represent identical medical symptoms and will be treated and followed by their GP as usual. They will, however, be informed and asked to consign to participate in the study, and will respond to the same questionnaires as the patients in the intervention group.

Interventions

BEHAVIORALICIT

Patients in the intervention group will receive a number of consultations with their GP based on the ICIT

Sponsors

University of Oslo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Cluster Randomized Controlled Trial with an intervention group and a control group

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
No

Inclusion criteria

* Patients must have a condition the GP deems as MUPS (unspecific og generalized pain, fatigue or mood disturbances without being depressed) * Patients must be deemed satisfactory clinical examined without specific findings * Patients must be able to speak and understand Norwegian language without interpreter * Patients must sign on a consignment form

Exclusion criteria

* Patients must not have any well defined psychiatric diagnosis * Patients must not have any alcohol or drug abuse * Patients must not be using more than 10 mg Benzodiasepine per day

Design outcomes

Primary

MeasureTime frameDescription
Patients' assessment of personal quality of lifeOne yearPatients Global Impression of Change (PGIC)
Patients' experiences at the encounterOne yearMean change on score at the Patient Experiences Questionnaire (PEQ)

Secondary

MeasureTime frameDescription
The primary outcome is any change in patient's coping strategiesOne yearMean change on score at the Patient Activation Measure (PAM) in both groups

Other

MeasureTime frameDescription
Single questionOne yearPatients will be asked about their own anticipation of return to work

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026